CLB FY 2009 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2009 Earnings

Reported February 19, 2010

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2009	Prior Q	FY 2008	QoQ Change	YoY Change
Revenue	$696M	—	$781M	—	-10.9%
Op. Income	$187M	—	$207M	—	-9.6%
Gross Margin	34.2%	—	34.1%	—	0.1pp
Net Margin	16.3%	—	18.4%	—	-2.1pp
EPS (Diluted)	$2.43	—	$2.74	—	-11.3%
Free Cash Flow	$164M	—	$124M	—	32.6%

Revenue Flow

Item	Amount
REVENUE	$696M
Cost of Revenue	$458M
GROSS PROFIT	$238M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$30M
Other Expenses	$21M
Operating Expenses	$51M
Cost & Expenses	$509M
OPERATING INCOME	$187M
Interest Income	$0
Interest Expense	$16M
Other Income/Expenses	-$16M
INCOME BEFORE TAX	$171M
Income Tax Expense	$57M
Net Income from Continuing Ops	$114M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$114M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$114M
D&A	$24M
EBIT	$187M
EBITDA	$211M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$696M
Cost of Revenue	$458M
GROSS PROFIT	$238M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$30M
Other Expenses	$21M
Operating Expenses	$51M
Cost & Expenses	$509M
OPERATING INCOME	$187M
Interest Income	$0
Interest Expense	$16M
Other Income/Expenses	-$16M
INCOME BEFORE TAX	$171M
Income Tax Expense	$57M
Net Income from Continuing Ops	$114M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$114M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$114M
D&A	$24M
EBIT	$187M
EBITDA	$211M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$114M
Depreciation & Amortization	$24M
Stock-Based Compensation	$6M
Deferred Income Tax	$26M
Other Non-Cash Items	$14M
Change in Working Capital	-$2M
OPERATING CASH FLOW	$182M
Capital Expenditure	-$18M
Acquisitions (Net)	-$12M
Purchases of Investments	-$2M
Sales/Maturities of Investments	$0
Other Investing Activities	-$17M
NET CASH FROM INVESTING	-$19M
Net Debt Issuance	$0
Common Stock Repurchased	-$9M
Common Dividends Paid	-$26M
Other Financing Activities	$18M
NET CASH FROM FINANCING	-$18M
FREE CASH FLOW	$164M
Net Change in Cash	$145M

Balance Sheet

Item	Amount
Cash & Equivalents	$181M
Short-Term Investments	$0
Net Receivables	$134M
Inventory	$32M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$391M
PP&E (Net)	$99M
Goodwill	$149M
Intangible Assets	$7M
Long-Term Investments	-$14M
Tax Assets	$14M
Other Non-Current Assets	$14M
TOTAL NON-CURRENT ASSETS	$268M
TOTAL ASSETS	$658M
Account Payables	$33M
Short-Term Debt	$0
Deferred Revenue	$17M
Other Current Liabilities	$34M
TOTAL CURRENT LIABILITIES	$106M
Long-Term Debt	$209M
Deferred Revenue NC	$17M
Deferred Tax Liabilities	$8M
Other Non-Current Liabilities	$36M
TOTAL NON-CURRENT LIABILITIES	$270M
TOTAL LIABILITIES	$376M
Common Stock	$1M
Additional Paid-In Capital	$62M
Retained Earnings	$469M
Treasury Stock	-$247M
Accum. Other Comp. Income	$0
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$279M
Minority Interest	$2M
TOTAL EQUITY	$282M
TOTAL LIABILITIES & EQUITY	$658M
Total Debt	$209M
Net Debt	$28M